CDTConduit Pharmaceuticals Inc. Common Stock
2.860USD-1.38%Mkt Cap: 2.25M $P/E: —3d ago
CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials …
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap2.25M $
Enterprise Value2.72M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-39.22M $
Revenue/Share—
Last Price2.860 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.12
EV/Revenue—
P/S—
P/B-0.04
EPS (TTM)-2978.78
EPS (Forward)—
52W Range
2.5300% of range3460.00
52W High3460.00 USD
52W Low2.530 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE547.06%
ROA-694.23%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-15.55M $
CapEx (TTM)2.40M $
FCF Margin—
FCF Yield871.91%
Net Debt435.00K $
Net Debt/EBITDA-0.02
Balance Sheet
Debt/Equity-0.11
Current Ratio0.13
Quick Ratio0.04
Book Value/Sh-77.8160 USD
Cash/Share0.9500 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:10
Split DateJul 20, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.786.67K
Float752.12K
Insiders22.94%
Institutions2.15%
Short Interest
Short Ratio0.3d
Short % Float4.55%
Short % Out.2.88%
Shares Short18.20K
Short (prev mo.)16.77K
Technical
SMA 504.755 (-39.9%)
SMA 200175.92 (-98.4%)
Beta1.49
S&P 52W Chg18.16%
Avg Vol (30d)61.02K
Avg Vol (10d)33.26K
Technical Indicators
RSI (14)38.5
MACD-0.6393
MACD Signal-0.8479
MACD Hist.+0.2086
BB Upper3.469 USD
BB Middle2.995 USD
BB Lower2.520 USD
BB Width31.69%
ATR (14)0.5845 USD
Vol Ratio (20d)1.33x